Does Dr. FNU ARCHANA GUNDIGI VENKATESH have financial conflicts of interest?

Dr. FNU ARCHANA GUNDIGI VENKATESH (MD) has received a total of $47 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $47 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. FNU ARCHANA GUNDIGI VENKATESH?

According to CMS Open Payments data, Dr. FNU ARCHANA GUNDIGI VENKATESH received funding from EAGLE PHARMACEUTICALS ($28) and PACIRA PHARMACEUTICALS INCORPORATED ($20).

Does Dr. FNU ARCHANA GUNDIGI VENKATESH receive research grants or speaking fees?

Dr. FNU ARCHANA GUNDIGI VENKATESH has received $47 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. FNU ARCHANA GUNDIGI VENKATESH

MDReal-Time Hydrated

Specialty: Anesthesiology

Practice Location: MEMPHIS, TN 38103

NPI Number: 1508388869

LIFETIME INDUSTRY VALUE

$47

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ARCHANA GUNDIGI VENKATESH is a verified Anesthesiology practitioner based in MEMPHIS, TN.

Between 2021 and 2025, Dr. ARCHANA GUNDIGI VENKATESH had an overall industry promotional and research financial footprint of $47 as recorded in the federal CMS Open Payments database.

$47 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ARCHANA GUNDIGI VENKATESH's primary funding source is EAGLE PHARMACEUTICALS, which accounts for $28 (representing 58.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

EAGLE PHARMACEUTICALS

Rank 1

$28

58.3%

PACIRA PHARMACEUTICALS INCORPORATED

Rank 2

$20

41.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.